ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
ALUMIS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.34+0.22 (+3.59%)
Close on Oct 19, 2026
- Market cap
- $809.56M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.85 (+41.20%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ALUMIS INC. reported revenue of $7.40M for the twelve months to Jun 30, 2026. Free cash flow was -$351.80M.
Revenue
$7.40M
TTM Q2 2026
Operating income
-$459.00M
TTM Q2 2026
Free cash flow
-$351.80M
TTM Q2 2026
EPS, diluted
-$3.80
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $809.56M
- P/E ratio
- –
- Price to sales
- 109.43
- Price to book
- 1.79
- Dividend yield
- –
- Free cash flow yield
- -43.46%
Fundamentals
- Revenue
- $7.40M
- Net income
- -$438.96M
- EPS, diluted
- -$3.80
- Free cash flow
- -$351.80M
- Book value per share
- $3.54
- Diluted shares
- 128M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$7.40M
Operating income
-$459.00M
Net income
-$438.96M
EPS, diluted
-$3.80
Free cash flow
-$351.80M
Reported periodTrailing twelve months